MELISSA FELDER: Open Payments
NPI 1104320738 · COLUMBIA, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$592 in 10 payments from 7 companies in 2025. Trend: 2023 $755 · 2024 $569 · 2025 $592
Food & beverage: $592
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $145 |
| ViiV Healthcare Company | 1 | $118 |
| Alkermes, Inc. | 1 | $107 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $88 |
| Gilead Sciences, Inc. | 1 | $81 |
| Novo Nordisk Inc | 2 | $36 |
| Phathom Pharmaceuticals, Inc. | 1 | $17 |
Products named: AIRSUPRA, LYBALVI, Kerendia, Ozempic, VOQUEZNA, Rybelsus.
Industry payments across SC — which companies pay providers there.
